O

Onxeo SA
PAR:ALONX

Watchlist Manager
Onxeo SA
PAR:ALONX
Watchlist
Price: 0.272 EUR 0.74% Market Closed
Market Cap: 30.2m EUR

Wall Street
Price Targets

ALONX Price Targets Summary
Onxeo SA

There are no price targets for ALONX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Onxeo SA Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
15% Upside
2171
CARsgen Therapeutics Holdings Ltd
16% Upside
2487
Cutia Therapeutics
46% Upside
RLAY
Relay Therapeutics Inc
197% Upside
EXEL
Exelixis Inc
14% Upside
TGTX
TG Therapeutics Inc
23% Upside
MGNX
MacroGenics Inc
100% Upside
600201
Jinyu Bio-Technology Co Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
Onxeo SA

For the last 6 years the compound annual growth rate for Onxeo SA's revenue is -17%. The projected CAGR for the next 2 years is 702%.

-17%
Past Growth
702%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Onxeo SA

Operating Income forecast
is not available for
Onxeo SA

Net Income
Forecast

Net Income Estimate
Onxeo SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALONX's stock price target?
Not Available

ALONX doesn't have any price targets made by Wall Street professionals.

What is Onxeo SA's Revenue forecast?
Projected CAGR
702%

For the last 6 years the compound annual growth rate for Onxeo SA's revenue is -17%. The projected CAGR for the next 2 years is 702%.

Back to Top